Nephrology News
Some High-risk Heart Failure Patients Benefit From MRAs
Mineralocorticoid receptor antagonists found to lower hospital readmission risk in patients with heart failure and concomitant diabetes or renal insufficiency.
By accepting you will be accessing a service provided by a third-party external to https://www.galencarepartners.com/